Dr. Amy N. Sanford, MD

Dr. Sanford practices at Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health.

Dr. Sanford's NPI, 1679708283, was assigned on May 27, 2009. Dr. Sanford holds South Dakota license 9480.

Dr. Sanford's primary practice is Avera McKennan Hospital & University Health Center, at 1325 S Cliff Ave Post Office Box 5045, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 322-8000.

Dr. Sanford's primary practice is Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health. Dr. Sanford is also affiliated with Spencer Hospital. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Sanford to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanford practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sanford's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sanford's licenses on file in 2 states: South Dakota and Iowa.

CMS data shows 966 Medicare services from Dr. Sanford across 8 procedure codes in 2024, for 203 Medicare patients. Medicare paid $78,466 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Dr. Sanford in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanford's median patient age at 71, with 45% women.

In 2024, Dr. Sanford wrote 582 Medicare Part D claims for 105 patients. 87% of them were for generic drugs. CMS names the drug for 397 of them, across 13 drugs with 11 or more claims each, at $729,284 in total drug cost. In 2023, CMS named 334 claims across 13 drugs.

Dr. Sanford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanford as offering telehealth.

Dmand AI links 4 papers to Dr. Sanford, published from 2021 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Camptothecin. Dr. Sanford has published most often in Nat Med. Dr. Sanford's most frequent co-authors are Mili Arora, MD, Heather Christine Beckwith, MD and Amy S. Clark, MD.

Dmand AI links Dr. Sanford to 5 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Breast Neoplasms. Washington University School of Medicine sponsors the most, 2. Open Payments lists research payments to Dr. Sanford that name 1 trial.

CMS Open Payments shows 4 general payments to Dr. Sanford from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 57% of the total. Daiichi Sankyo Inc. paid the most, $31. It also lists 3 research payments totaling $1,498 from 2018 to 2019, naming 1 clinical trial.